Form 4 holding
S.V.P., General Counsel
ARCA biopharma, Inc.
- Security class
- Common Stock
- Shares / value
- 50,970
- Estimated value
- $127,425
- Report date
- 14 Dec 2021
- Price
- $2.50
- Ownership
- Direct
Christopher David Ozeroff - S.V.P., General Counsel at Oruka Therapeutics, Inc.
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- S.V.P., General Counsel
- Issuer Symbol
- ORKA on Nasdaq
- All Insider Reports
- All Insider Reports
There are no Buy or Sell transactions made by Christopher David Ozeroff since 26 May 2025
Holdings reported by Christopher David Ozeroff for Oruka Therapeutics, Inc.
Form 4 holding
S.V.P., General Counsel
ARCA biopharma, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 27,500
- Estimated value
- Report date
- 14 Dec 2021
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by Christopher David Ozeroff for Oruka Therapeutics, Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.